Cozzi Sarah-Jane, Le Thuy T, Ogbourne Steven M, James Cini, Suhrbier Andreas
Inflammation Biology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane.
Genecology Research Center, Faculty of Science, Health, Engineering and Education, University of the Sunshine Coast, Maroochydore DC, QLD, Australia.
Clin Cosmet Investig Dermatol. 2017 May 25;10:205-210. doi: 10.2147/CCID.S135716. eCollection 2017.
An increasing number of people are getting tattoos; however, many regret the decision and seek their removal. Lasers are currently the most commonly used method for tattoo removal; however, treatment can be lengthy, costly, and sometimes ineffective, especially for certain colors. Ingenol mebutate is a licensed topical treatment for actinic keratoses. Here, we demonstrate that two applications of 0.1% ingenol mebutate can efficiently and consistently remove 2-week-old tattoos from SKH/hr hairless mice. Treatment was associated with relocation of tattoo microspheres from the dermis into the posttreatment eschar. The skin lesion resolved about 20 days after treatment initiation, with some cicatrix formation evident. The implications for using ingenol mebutate for tattoo removal in humans are discussed.
越来越多的人开始纹身;然而,许多人后悔了这个决定并寻求去除纹身。激光是目前最常用的纹身去除方法;然而,治疗过程可能漫长、昂贵,有时还无效,尤其是对于某些颜色的纹身。鬼臼毒素是一种用于治疗光化性角化病的外用处方药。在此,我们证明,对SKH/ hr无毛小鼠使用两次0.1%的鬼臼毒素,能够有效且持续地去除其两周大的纹身。治疗导致纹身微球从真皮层转移到治疗后的焦痂中。治疗开始约20天后,皮肤损伤愈合,有明显的瘢痕形成。本文还讨论了将鬼臼毒素用于人类纹身去除的潜在意义。